Difficulty: Medium
Average Score: 67%
Practice
A client is being assessed by a healthcare provider while taking Digoxin to manage heart failure. Which of the following findings is a manifestation of digoxin toxicity?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Report of anorexia. Digoxin toxicity can present with gastrointestinal symptoms like anorexia, nausea, vomiting, and abdominal pain. Anorexia is particularly common in cases of digoxin toxicity due to its impact on the gastrointestinal system. This symptom should prompt immediate assessment and potential adjustment of the digoxin dosage to prevent further complications.
Option A) Bruising is not typically associated with digoxin toxicity. Bruising may be related to other factors such as blood clotting abnormalities or trauma.
Option B) Report of metallic taste is not a common manifestation of digoxin toxicity. Metallic taste is more commonly associated with certain medications or oral health issues.
Option C) Muscle pain is not a typical sign of digoxin toxicity. Muscle pain could be due to various reasons like strain, injury, or other medications but is not specifically linked to digoxin toxicity.
Understanding the manifestations of digoxin toxicity is crucial for healthcare providers to ensure safe medication management for patients with heart failure. Regular monitoring, patient education, and prompt recognition of toxic symptoms are essential aspects of pharmacological care in such cases.
Option A) Bruising is not typically associated with digoxin toxicity. Bruising may be related to other factors such as blood clotting abnormalities or trauma.
Option B) Report of metallic taste is not a common manifestation of digoxin toxicity. Metallic taste is more commonly associated with certain medications or oral health issues.
Option C) Muscle pain is not a typical sign of digoxin toxicity. Muscle pain could be due to various reasons like strain, injury, or other medications but is not specifically linked to digoxin toxicity.
Understanding the manifestations of digoxin toxicity is crucial for healthcare providers to ensure safe medication management for patients with heart failure. Regular monitoring, patient education, and prompt recognition of toxic symptoms are essential aspects of pharmacological care in such cases.